The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $89.78

Today's change+1.11 +1.25%
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $89.78

Today's change+1.11 +1.25%
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.

Varian Medical Systems Inc crosses above 20-day moving average

Varian Medical Systems Inc closed up Friday by (U.S.)$1.11 or 1.25% to (U.S.)$89.78 and crossing above its 20-day moving average. Shares have lost 2.56% over the last five days, but have gained 11.11% over the last year to date. This security has outperformed the S&P 500 by 5.09% during the last year.

Key company metrics

  • Open(U.S.) $89.27
  • Previous close(U.S.) $88.67
  • High(U.S.) $90.00
  • Low(U.S.) $88.51
  • Bid / Ask-- / --
  • YTD % change+11.11%
  • Volume557,818
  • Average volume (10-day)722,059
  • Average volume (1-month)1,152,012
  • Average volume (3-month)844,175
  • 52-week range(U.S.) $73.18 to (U.S.) $106.70
  • Beta0.66
  • Trailing P/E21.39×
  • P/E 1 year forward17.99×
  • Forward PEG1.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.20
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.51%

Based on its net profit margin of 12.51%, Varian Medical Systems Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jul 01, 201607/01/2016Apr 01, 201604/01/2016Jan 01, 201601/01/2016
Revenue912789759757
Total other revenue--------
Total revenue912789759757
Gross profit388346317310
Total cost of revenue525443442447
Total operating expense743659625640
Selling / general / administrative133153109140
Research & development66656260
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)17------
Other operating expenses, total--------
Operating income170130134117
Interest income (expense), net non-operating-3-3-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax171132135118
Income after tax118999789
Income tax, total53333829
Net income118999789
Total adjustments to net income--------
Net income before extra. items118999789
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items118999789
Inc. avail. to common incl. extra. items118999789
Diluted net income118999789
Dilution adjustment00--0
Diluted weighted average shares94959698
Diluted EPS excluding extraordinary itemsvalue per share1.241.041.010.91
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.371.041.010.91